Myxoma of the heart (RCD code: VI-1A.1)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2013, Vol 1, Issue 4
Abstract
Myxomas are the most common primary benign intracardiac tumors. Typically they locate in the left atrium (LA) or right atrium (RA) and are composed of cells, that originate from multipotent mesenchyme. The clinical manifestations of myxomas depend on the anatomic location of the tumor, its size, as well as its mobility. We present two case reports that concern the management of myxoma. The first diagnostic approach for assessment of the myxomas is two dimensional echocardiography. Computed tomography (CT) and Magnetic Resonance (MR) play especially role in providing diagnostic information useful toward surgical planning. Surgical operation and resection of the myxoma is a definite and curative therapy The risk for recurrence of the myxoma is about 2–5 %. The annual clinical surveillance and echocardiographic assesment is reccomended to all patients who undergo a myxoma operation.. JRCD 2013; 1 (4): 29–32
Authors and Affiliations
Hanna Dziedzic-Oleksy, Monika Komar, Maria Olszowska, Małgorzata Urbańczyk-Zawadzka, Barbara Widlińska, Robert Banyś, Piotr Podolec
Left atrial myxoma as a cause of multiple cerebral microembolization (RCD code: VI‐1A.1)
We report a case of a 56-year-old female after breast cancer treatment, who was diagnosed with left atrial myxoma as a rare cause of cerebral and cerebellar stroke.JRCD 2017; 3 (5): 168–170
JRCD is now an open‑access journal and also accepts high‑quality papers beyond the field of rare cardiovascular diseases and disorders
n/a
“One of the greatest disease is to be nobody to anybody”
Saint Mother Teresa of CalcuttaDear Readers,Before we go any further, try to ponder the quote once said by the Saint Teresa of Calcutta. She was by far one of the most entitled person in the world to say such an unpleasa...
Macitentan therapy for bosentan hepatic intolerance in Eisenmenger’s syndrome patient. (RCD code: II-1A.4d)
Pulmonary arterial hypertension associated with congenital heart disease is included in clinical group 1 pulmonary arterial hypertension. Eisenmenger’s syndrome develops over time as a result of large intra- and extra-ca...
Nitric oxide signaling in the ischemic postconditioning of human heart muscle (RCD code: III)
Background: Ischemic heart conditioning is well documented to trigger the intrinsic protective mechanisms of resistance against ischemia/reperfusion (I/R) injury. Previous studies on animal model have suggested that the...